Cargando…
Two Patients With Brain Tumors Who Received Bevacizumab and Radiotherapy: Optic Neuropathy and Quality-of-Life Issues
Autores principales: | Fu, D. Beverly, Alexandru, Daniela, Curticiu, Dana M., Fu*, Yao, Bota, Daniela A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Harborside Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4093434/ https://www.ncbi.nlm.nih.gov/pubmed/25032005 |
Ejemplares similares
-
Non-arteritic ischemic optic neuropathy followed by intravitreal bevacizumab injection: Is there an association?
por: Bodla, Ali A, et al.
Publicado: (2010) -
The Risk of Non-arteritic Ischemic Optic Neuropathy Post-intravitreal Bevacizumab Injection
por: Fugara, Nasser A, et al.
Publicado: (2022) -
Phase II study of ERC1671 plus bevacizumab versus bevacizumab plus placebo in recurrent glioblastoma: interim results and correlations with CD4(+) T-lymphocyte counts
por: Bota, Daniela A, et al.
Publicado: (2018) -
A Prospective, Cohort Study of SITOIGANAP to Treat Glioblastoma When Given in Combination With Granulocyte-Macrophage Colony-Stimulating Factor/Cyclophosphamide/Bevacizumab/Nivolumab or Granulocyte-Macrophage Colony-Stimulating Factor/Cyclophosphamide/Bevacizumab/Pembrolizumab in Patients Who Failed Prior Treatment With Surgical Resection, Radiation, and Temozolomide
por: Bota, Daniela A., et al.
Publicado: (2022) -
An unusual presentation of nonarteritic ischemic optic neuropathy with subretinal fluid treated with intravitreal bevacizumab
por: Dave, Vivek Pravin, et al.
Publicado: (2016)